| Issue Date | Title | Author(s) |
| 2004-11-01 | Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus | Wang, XY; Martiniello-Wilks, R; Shaw, JM; Ho, T; Coulston, N; Cooke-Yarborough, C; Molloy, PL; Cameron, F; Moghaddam, M; Lockett, TJ; Webster, LK; Smith, IK; Both, GW; Russel, PJ |
| 2013-01-01 | Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy | Ren, B; O'Brien, BA; Byrne, MR; Ch'ng, E; Gatt, PN; Swan, MA; Nassif, NT; Wei, MQ; Gijsbers, R; Debyser, Z; Simpson, AM |
| 1998-07-20 | In vivo gene therapy for prostate cancer: Preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors | Martiniello-Wilks, R; Garcia-Aragon, J; Daja, MM; Russell, P; Both, GW; Molloy, PL; Lockett, LJ; Russell, PJ |
| 2002-01-01 | Transcription-targeted gene therapy for androgen-independent prostate cancer | Martiniello-Wilks, R; Tsatralis, T; Russell, P; Brookes, DE; Zandvliet, D; Lockett, LJ; Both, GW; Molloy, PL; Russell, PJ |
| 2013-06-01 | Prokaryotic expression and purification of soluble maize Ac transposase | Lamb-Palmer, ND; Singh, M; Dalton, JP; Singh, J |
| 2004-04-23 | Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: Propeptide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells | Collins, PR; Stack, CM; O'Neill, SM; Doyle, S; Ryan, T; Brennan, GP; Mousley, A; Stewart, M; Maule, AG; Dalton, JP; Donnelly, S |
| 2016-04 | New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial Promoters. | Kanno, AI; Goulart, C; Rofatto, HK; Oliveira, SC; Leite, LCC; McFadden, J |
| 2017-02 | A Tol2 Gateway-Compatible Toolbox for the Study of the Nervous System and Neurodegenerative Disease. | Don, EK; Formella, I; Badrock, AP; Hall, TE; Morsch, M; Hortle, E; Hogan, A; Chow, S; Gwee, SSL; Stoddart, JJ; Nicholson, G; Chung, R; Cole, NJ |
| 2004-12-01 | Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer | Martiniello-Wilks, R; Wang, XY; Voeks, DJ; Dane, A; Shaw, JM; Mortensen, E; Both, GW; Russell, PJ |
